De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Zimmer Biomet Holdings Toekomstige groei
Future criteriumcontroles 1/6
Zimmer Biomet Holdings zal naar verwachting groeien in winst en omzet met respectievelijk 9.7% en 4.4% per jaar. De winst per aandeel zal naar verwachting groeien met 10.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 14.1% zijn.
Belangrijke informatie
9.7%
Groei van de winst
10.9%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 17.5% |
| Inkomstengroei | 4.4% |
| Toekomstig rendement op eigen vermogen | 14.1% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 03 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up
Oct 03
Zimmer Biomet: The Undervalued Titan Of Joint Replacements
Oct 02Zimmer Biomet Stock: Don't Jump In At The 52-Week Low
Sep 19We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)
Sep 18Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Sep 02Zimmer Biomet Holdings (NYSE:ZBH) Seems To Use Debt Quite Sensibly
Aug 27Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 45%?
Jul 15Investors Interested In Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Earnings
Jul 02Zimmer Biomet: Brighter Prospects In H2 2024
Jul 02Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24
Jun 19When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Jun 05Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24
May 21Zimmer Biomet Holdings: Moving Along
May 17The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising
May 02Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality
Feb 15What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?
Feb 11Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Jan 29Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar
Jan 15The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
Dec 31Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution
Dec 18Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly
Dec 17Zimmer Biomet: Still Many Questions After A Solid Year So Far
Nov 26When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Nov 06Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching
Oct 07Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes
Sep 21Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence
Sep 14Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Sep 06Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy
Aug 11Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Aug 08Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Jul 10We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease
Jun 27Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Jun 13A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 30Zimmer Biomet: Expect Growth Momentum To Continue
May 26Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
May 04At US$129, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?
Apr 02Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Appealing
Mar 13A Look At The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Feb 21Improving Ortho Performance At Zimmer Biomet Is Encouraging
Feb 09Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 8,431 | 1,280 | 1,719 | 2,188 | 21 |
| 12/31/2025 | 8,054 | 1,144 | 1,499 | 2,073 | 27 |
| 12/31/2024 | 7,682 | 982 | 1,059 | 1,532 | 26 |
| 6/30/2024 | 7,525 | 997 | 821 | 1,523 | N/A |
| 3/31/2024 | 7,452 | 964 | 807 | 1,502 | N/A |
| 12/31/2023 | 7,394 | 1,024 | 892 | 1,582 | N/A |
| 9/30/2023 | 7,279 | 474 | 560 | 1,237 | N/A |
| 6/30/2023 | 7,196 | 506 | 724 | 1,351 | N/A |
| 3/31/2023 | 7,108 | 450 | 858 | 1,355 | N/A |
| 12/31/2022 | 6,940 | 290 | 839 | 1,285 | N/A |
| 9/30/2022 | 6,892 | 366 | 970 | 1,406 | N/A |
| 6/30/2022 | 6,908 | 334 | 957 | 1,389 | N/A |
| 3/31/2022 | 6,889 | 325 | 1,078 | 1,490 | N/A |
| 12/31/2021 | 6,827 | 445 | 1,074 | 1,499 | N/A |
| 9/30/2021 | 7,135 | 834 | 1,164 | 1,559 | N/A |
| 6/30/2021 | 7,379 | 914 | 1,132 | 1,507 | N/A |
| 3/31/2021 | 6,842 | 563 | 618 | 1,000 | N/A |
| 12/31/2020 | 6,128 | -11 | 834 | 1,205 | N/A |
| 9/30/2020 | 7,065 | -152 | 762 | 1,203 | N/A |
| 6/30/2020 | 7,028 | 37 | 899 | 1,399 | N/A |
| 3/31/2020 | 7,791 | 377 | 1,008 | 1,753 | N/A |
| 12/31/2019 | 7,982 | 1,132 | 865 | 1,586 | N/A |
| 9/30/2019 | 7,928 | -90 | 830 | 1,542 | N/A |
| 6/30/2019 | 7,872 | -359 | 750 | 1,448 | N/A |
| 3/31/2019 | 7,891 | -308 | 1,087 | 1,541 | N/A |
| 12/31/2018 | 7,933 | -379 | 1,308 | 1,747 | N/A |
| 9/30/2018 | 7,930 | 1,753 | 1,324 | 1,771 | N/A |
| 6/30/2018 | 7,907 | 1,690 | 1,324 | 1,750 | N/A |
| 3/31/2018 | 7,849 | 1,689 | N/A | 1,797 | N/A |
| 12/31/2017 | 7,803 | 1,814 | N/A | 1,582 | N/A |
| 9/30/2017 | 7,748 | 652 | N/A | 1,807 | N/A |
| 6/30/2017 | 7,768 | 712 | N/A | 1,696 | N/A |
| 3/31/2017 | 7,752 | 497 | N/A | 1,635 | N/A |
| 12/31/2016 | 7,668 | 306 | N/A | 1,632 | N/A |
| 9/30/2016 | 7,604 | 363 | N/A | 1,468 | N/A |
| 6/30/2016 | 7,534 | 227 | N/A | 1,214 | N/A |
| 3/31/2016 | 6,767 | 84 | N/A | 1,031 | N/A |
| 12/31/2015 | 5,998 | 147 | N/A | 850 | N/A |
| 9/30/2015 | 5,287 | 174 | N/A | 742 | N/A |
| 6/30/2015 | 4,631 | 325 | N/A | 899 | N/A |
| 3/31/2015 | 4,646 | 670 | N/A | 956 | N/A |
| 12/31/2014 | 4,673 | 720 | N/A | 1,061 | N/A |
| 9/30/2014 | 4,691 | 802 | N/A | 999 | N/A |
| 6/30/2014 | 4,659 | 784 | N/A | 1,036 | N/A |
| 3/31/2014 | 4,646 | 764 | N/A | 971 | N/A |
| 12/31/2013 | 4,623 | 780 | N/A | 963 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei ZBH ( 9.7% per jaar) ligt boven de spaarquote ( 2.5% ).
Winst versus markt: De winst van ZBH ( 9.7% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.2% per jaar).
Hoge groeiwinsten: De winst van ZBH zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van ZBH ( 4.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.7% per jaar).
Hoge groei-inkomsten: De omzet van ZBH ( 4.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen ZBH zal naar verwachting over 3 jaar laag zijn ( 14.1 %).